A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder

Journal of Clinical Psychiatry

Volumn 71, Issue 5, 2010, Pages 548-556

  Wilens, Timothy E ^a,b   Hammerness, Paul ^a,b   Martelon, Marykate ^a   Brodziak, Kerry ^a   Utzinger, Linsey ^a   Wong, Patricia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

AGORAPHOBIA; APPLICATION SITE PRURITUS; ARTICLE; ATTENTION DEFICIT DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FUNCTIONAL STATUS; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HUMAN; INSOMNIA; IRRITABILITY; MAJOR DEPRESSION; MALE; MOLLUSCUM CONTAGIOSUM; OBSERVATION; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL DEFIANT DISORDER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCHOOL; SCHOOL CHILD; SEPARATION ANXIETY; SIDE EFFECT; SOCIAL PHOBIA; SYMPTOM; TIC; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR;

ADMINISTRATION, CUTANEOUS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD BEHAVIOR; CROSS-OVER STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PARENTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHOOLS;

EID: 77952624423     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05779pur     Document Type: Article

References (36)

1. Bloom B, Dey AN. Summary health statistics for US children: National Health Interview Survey, 2004. Vital Health Stat 10. 2006;(227):1-85.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
3. Whalen CK, Henker B, Jamner LD, et al. Toward mapping daily challenges of living with ADHD: maternal and child perspectives using electronic diaries. J Abnorm Child Psychol. 2006;34(1):115-130. (Pubitemid 43800468)
4. Barkley RA, Cunningham CE. The effects of methylphenidate on the mother-child interactions of hyperactive children. Arch Gen Psychiatry. 1979;36(2):201-208. (Pubitemid 9098806)
5. Wilens TE, Spencer T. The stimulants revisited. In: Stubbe C, ed. Child and Adolescent Psychiatric Clinics of North America. 3rd ed. Philadelphia, PA: Saunders; 2000: 573-603.
6. Greenhill LL, Findling RL, Swanson JM; ADHD Study Group. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002; 109(3):e39.
7. Cunningham CE, Barkley RA. The effects of methylphenidate on the mother-child interactions of hyperactive identical twins. Dev Med Child Neurol. 1978;20(5):634-642.
8. Cunningham CE, Barkley RA. The interactions of normal and hyperactive children with their mothers in free play and structured tasks. Child Dev. 1979;50(1):217-224.
9. Block SL, Kelsey D, Coury D, et al. Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing. Clin Pediatr (Phila). 2009;48(7):723-733.
10. Swanson J, Lerner M, Gupta S, et al. Development of a new once-a- day formulation of methylphenidate for the treatment of ADHD: proof of concept and proof of product studies. Arch Gen Psychiatry. 2003;60(2):204-211.
11. McGough JJ, Wigal SB, Abikoff H, et al. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord. 2006; 9(3):476-485. (Pubitemid 43171141)
12. Whalen CK, Henker B, Ishikawa SS, et al. Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study. J Atten Disord. 2010;13(4):391-400.
13. Wehmeier PM, Schacht A, Lehmann M, et al. Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/ hyperactivity disorder: findings from a patient, parent and physician perspective using items from the Pediatric Adverse Event Rating Scale (PAERS). Child Adolesc Psychiatry Ment Health. 2008;2(1):11. (Pubitemid 351877829)
14. Pelham WE Jr, Manos MJ, Ezzell CE, et al. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005;44(6):522-529. (Pubitemid 40720951)
15. Wilens TE, Boellner SW, López FA, et al. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008;47(6):700-708.
16. Findling RL, Bukstein OG, Melmed RD, et al. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008;69(1):149-159.
17. Pierce D, Dixon CM, Wigal SB, et al. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study. J Child Adolesc Psychopharmacol. 2008;18(4):355-364.
18. Daytrana [package insert]. Dublin, Ireland: Shire Pharmaceuticals Ireland Limited; 2006
19. Ambrosini PJ. Historical development and present status of the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS). J Am Acad Child Adolesc Psychiatry. 2000;39(1):49-58.
20. DuPaul G, Power T, Anastopoulos A, et al. ADHD Rating Scale IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
22. Faries D, Yalcin I, Harder D, et al. Validation of the ADHD Rating Scale as a clinician administered and scored instrument. J Atten Disord. 2001;5(2):107-115. (Pubitemid 33794656)
23. Conners CK, Sitarenios G, Parker JD, et al. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998;26(4):257-268. (Pubitemid 28359774)
24. National Institute of Mental Health. CGI (Clinical Global Impression Scale). Psychopharmacol Bull. 1985;21:839-844.
25. Gioia GA, Isquith PK, Guy SC, et al. Behavior Rating Inventory of Executive Function. Child Neuropsychol. 2000;6(3):235-238.
26. Gioia GA, Isquith PK, Retzlaff PD, et al. Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychol. 2002;8(4):249-257.
27. Mahone EM, Cirino PT, Cutting LE, et al. Validity of the Behavior Rating Inventory of Executive Function in children with ADHD and/or Tourette syndrome. Arch Clin Neuropsychol. 2002;17(7):643-662.
28. Vriezen ER, Pigott SE. The relationship between parental report on the BRIEF and performance-based measures of executive function in children with moderate to severe traumatic brain injury. Child Neuropsychol. 2002;8(4):296-303.
29. Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1995;34(7): 886-896.
30. Tannock R, Schachar RJ, Carr RP, et al. Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol. 1989;17(5):473-491. (Pubitemid 19261803)
31. Abikoff H, Nissley-Tsiopinis J, Gallagher R, et al. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD. J Am Acad Child Adolesc Psychiatry. 2009;48(2):166-175.
32. Loeber R, Green SM, Lahey BB, et al. Differences and similarities between children, mothers, and teachers as informants on disruptive child behavior. J Abnorm Child Psychol. 1991;19(1):75-95.
33. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull. 1987;101(2):213-232.
34. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998; 316(7139):1236-1238.
35. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46.
36. Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 1995;142(9):904-908.